This is a preview of subscription content, log in via an institution to check access.
Notes
The study was funded by Baxalta SpA.
Reference
Viti R, et al. Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy. Clinical Drug Investigation : 6 Sep 2018. Available from: URL: http://doi.org/10.1007/s40261-018-0688-3
Rights and permissions
About this article
Cite this article
Antibody deficiencies requiring Ig replacement substantial burden. PharmacoEcon Outcomes News 812, 7 (2018). https://doi.org/10.1007/s40274-018-5274-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5274-7